Abstract
The aim of this work was to test the putative involvement of members of the ABC superfamily of transporters on folic acid (FA) cellular homeostasis in the human placenta. [3H]FA uptake and efflux in BeWo cells were unaffected or hardly affected by multidrug resistance 1 (MDR1) inhibition (with verapamil), multidrug resistance protein (MRP) inhibition (with probenecid) or breast cancer resistance protein (BCRP) inhibition (with fumitremorgin C). However, [3H]FA uptake and efflux were inhibited by progesterone (200 μM). An inhibitory effect of progesterone upon [3H]FA uptake and efflux was also observed in human cytotrophoblasts. Moreover, verapamil and ß-estradiol also reduced [3H]FA efflux in these cells. Inhibition of [3H]FA uptake in BeWo cells by progesterone seemed to be very specific since other tested steroids (β-estradiol, corticosterone, testosterone, aldosterone, estrone and pregnanediol) were devoid of effect. However, efflux was also inhibited by β-estradiol and corticosterone and stimulated by estrone. Moreover, the effect of progesterone upon the uptake of [3H]FA by BeWo cells was concentration-dependent (IC50 = 65 [range 9–448] μM) and seems to involve competitive inhibition. Also, progesterone (1–400 μM) did not affect either [3H]FA uptake or efflux at an external acidic pH. Finally, inhibition of [3H]FA uptake by progesterone was unaffected by either 4-acetamido-4′-isothiocyanato-2,2′-stilbenedisulfonic acid (SITS), a known inhibitor of the reduced folate carrier (RFC), or an anti-RFC antibody. These results suggest that progesterone inhibits RFC. In conclusion, our results show that progesterone, a sterol produced by the placenta, inhibits both FA uptake and efflux in BeWo cells and primary cultured human trophoblasts.
Similar content being viewed by others
References
Antony AC (1996) Folate receptors. Annu Rev Nutr 16:501–521
Assaraf YG, Rothem L, Hooijberg JH, Stark M, Ifergan I, Kathmann I, Dijkmans BA, Peters GJ, Jansen G (2003) Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells. J Biol Chem 278:6680–6686
Bailey-Dell KJ, Hassel B, Doyle LA, Ross DD (2001) Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta 1520:234–241
Barnes MK, Dickstein B, Cutler GB Jr, Fojo T, Bates SE (1996) Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells. Biochemistry 35:4820–4827
Borst P, Oude Elferink R (2002) Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537–592
Bradford MM (1976) A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Casey ML, MacDonald PC (1998) Endocrine changes of pregnancy. In: Wilson JD, Foster DW, Kronenberg HM, Larsen P (eds), Williams Textbook of Endocrinology, 9th ed, sect 8. Philadelphia: WB Saunders, pp 1259–1271
Chancy CD, Kekuda R, Huang W, Prasad PD, Kuhnel J-M, Sirotnak FM, Roon P, Ganapathy V, Smith SB (2000) Expression and differential polarization of the reduced-folate transporter-1 and the folate receptor α in mammalian retinal pigment epithelium. J Biol Chem 275:20676–20684
Chen Z-H, Robey RW, Belinsk MG, Shchaveleva I, Ren X-Q, Sugimoto Y, Ross DD, Bates SE, Kruh GD (2003) Transport of methotrexate, methotrexate polyglutamates, and 17ß-estradiol 17-(ß-d-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res 63:4048–4054
Chen Z-S, Lee K, Walther S, Raftogianis RB, Kuwano M, Zeng H, Kruh GD (2002) Analysis of methotrexate and folate transport by multidrug resistance protein 4: MRP4 is a component of the methotrexate efflux system. Cancer Res 62:3144–3150
Fromm MF (2004) Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 25:423–429
Hazlehurst LA, Foley NE, Gleason-Guzman MC, Hacker MP, Cress AE, Greenberger LW, De Jong MC, Dalton WS (1999) Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line. Cancer Res 59:1021–1028
Herbert V (1999) Folic acid. In: Shils ME, Olson JA, Shike M, Ross AH (eds), Modern Nutrition in Health and Disease, 9th ed. London: Lippincott, Williams & Wilkins, pp 433–446
Hooijberg JH, Peters GJ, Assaraf YG, Kathmann I, Priest DG, Bunni MA, Veerman AJ, Scheffer GL, Kaspers GJ, Jansen G (2003) The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis. Biochem Pharmacol 65:765–771
Ifergan I, Shafran A, Jansen G, Hooijberg JH, Scheffer GL, Assaraf YG (2004) Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis. J Biol Chem 279:25527–25534
Imai Y, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y (2002) Estrone and 17ß-estradiol reverse breast cancer resistance protein-mediated multidrug resistance. Jpn J Cancer Res 93:231–235
Keating E, Lemos C, Azevedo I, Martel F (2007) Acute and chronic effects of some dietary bioactive compounds on folic acid uptake and on the expression of folic acid transporters by the human trophoblast cell line BeWo. J Nutr Biochem (in press)
Keating E, Lemos C, Azevedo I, Martel F (2006) Comparison of folate uptake characteristics by human placental choriocarcinoma cells at acidic and physiological pH. Can J Physiol Pharmacol 84:247–255
Keating E, Lemos C, Costa F, Campos I, Azevedo I, Martel F (2005) Placental vitamin B9 uptake: characterization in human isolated cytotrophoblasts. Placenta 26:A48
Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF 3rd (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118:1567–1582
Lucock M (2000) Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Gen Metab 71:121–138
Matherly LH, Goldman ID (2003) Membrane transport of folates. Vitam Horm 66:403–456
McGuire JJ (2003) Anticancer antifolates: current status and future directions. Curr Pharm Des 9:2593–2613
Miyazaki H, Sekine T, Endou H (2004) The multispecific organic anion transporter family: properties and pharmacological significance. Trends Pharmacol Sci 25:654–662
Nakamura Y, Ikeda S, Furukawa T, Sumizawa T, Tani A, Akiyama S, Nagata Y (1997) Function of P-glycoprotein expressed in placenta and mole. Biochem Biophys Res Commun 235:849–853
Pascolo L, Fernetti C, Garcia-Mediavilla MV, Ostrow JD, Tiribelli C (2001) Mechanisms for the transport of unconjugated bilirubin in human trophoblastic BeWo cells. FEBS Lett 495:94–99
Picciano MF (2003) Pregnancy and lactation: physiological adjustments, nutritional requirements and the role of dietary supplements. J Nutr 133:1997S–2002S
Rabindran SK, Ross DD, Doyle LA, Yang W, Greenberger LM (2000) Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res 60:47–50
Schinkel AH, Jonker JW (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55:3–29
Sirotnak FM, Tolner B (1999) Carrier-mediated membrane transport of folates in mammalian cells. Annu Rev Nutr 19:91–122
Strauss JF III, Martinez F, Kiriakidou M (1996) Placental steroid hormone synthesis: unique features and unanswered questions. Biol Reprod 54:303–311
Sugawara I, Akiyama S, Scheper RJ, Itoyama S (1997) Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP. Cancer Lett 112:23–31
Tamimi R, Lagiou P, Vatten LJ, Mucci L, Trichopoulos D, Hellerstein S, Ekbom A, Adami H-O, Hsieh C-C (2003) Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring. Cancer Epidemiol Biomarkers Prev 12:647–650
Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioda N, Komano T, Hori R (1992) Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 267:24248–24252
Ushigome F, Takanaga H, Matsuo H, Yanai S, Tsukimori K, Nakano H, Uchiumi T, Nakamura T, Kuwano M, Ohtani H, Sawada Y (2000) Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol 408:1–10
Utoguchi N, Chandorkar GA, Avery M, Audus KL (2000) Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells. Reprod Toxicol 14:217–224
Worthington-Roberts BS (1999) Nutrition. In: Cohen WR, Cherry SH, Merkatz IR (eds), Cherry and Merkatz’s Complications of Pregnancy, 5th ed. London: Lippincott Williams & Wilkins, pp 17–49
Young AM, Allen CE, Audus KL (2003) Efflux transporters of the human placenta. Adv Drug Deliv Rev 55:125–132
Zeng H, Chen Z-S, Belinsky MG, Rea PA, Kruh GD (2001) Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res 61:7225–7232
Acknowledgment
This work was supported by FCT and Programa Ciência, Tecnologia e Inovação do Quadro Comunitário de Apoio (POCI/SAU-FCF/59382/2004) and the National Institutes of Health (NIH/NEI R01 EY12830).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keating, E., Gonçalves, P., Lemos, C. et al. Progesterone Inhibits Folic Acid Transport in Human Trophoblasts. J Membrane Biol 216, 143–152 (2007). https://doi.org/10.1007/s00232-007-9057-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-007-9057-5